Cargando…
TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
The aim of the present study was to explore the expression levels of tumor suppressor candidate 3 (TUSC3) in human clear cell renal cell carcinoma (ccRCC) and its clinical value. Immunohistochemical staining, western blotting and reverse transcription-quantitative polymerase chain reaction were used...
Autores principales: | Yan, Youji, Chen, Zhongjun, Liao, Yixiang, Zhou, Jiajie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507427/ https://www.ncbi.nlm.nih.gov/pubmed/31186719 http://dx.doi.org/10.3892/ol.2019.10161 |
Ejemplares similares
-
TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis
por: Liu, Fengqiong, et al.
Publicado: (2018) -
VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma
por: Ha, Mihyang, et al.
Publicado: (2019) -
Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma
por: Dong, Yang, et al.
Publicado: (2021) -
The relationship between serum albumin and prostate-specific antigen: A analysis of the National Health and Nutrition Examination Survey, 2003–2010
por: Xu, Kailiang, et al.
Publicado: (2023) -
TUSC3 Methylation in Peripheral Blood Cells as a Biomarker for Diagnosis of Colorectal Cancer
por: Siri, Goli, et al.
Publicado: (2023)